SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 226 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $158 | +5.3% | 7,300 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $150 | -56.3% | 7,300 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $343 | -99.8% | 7,300 | +55.3% | 0.00% | 0.0% |
Q3 2022 | $184,000 | -27.8% | 4,700 | -40.5% | 0.00% | 0.0% |
Q2 2022 | $255,000 | -80.5% | 7,900 | -65.8% | 0.00% | -80.0% |
Q2 2021 | $1,311,000 | +58.7% | 23,093 | +109.1% | 0.01% | +66.7% |
Q1 2021 | $826,000 | -78.0% | 11,043 | -78.8% | 0.00% | -81.2% |
Q4 2019 | $3,753,000 | -83.2% | 52,000 | -67.4% | 0.02% | -67.3% |
Q3 2019 | $22,344,000 | -0.4% | 159,284 | +30.0% | 0.05% | -51.0% |
Q2 2019 | $22,436,000 | -29.3% | 122,543 | -38.6% | 0.10% | -30.6% |
Q1 2019 | $31,730,000 | +44.0% | 199,500 | -13.3% | 0.14% | +28.6% |
Q4 2018 | $22,031,000 | +9.5% | 230,000 | +61.5% | 0.11% | +27.3% |
Q3 2018 | $20,116,000 | +505.9% | 142,417 | +571.4% | 0.09% | +528.6% |
Q2 2018 | $3,320,000 | -32.4% | 21,211 | -30.5% | 0.01% | -36.4% |
Q1 2018 | $4,912,000 | +4.3% | 30,500 | +6.6% | 0.02% | +10.0% |
Q4 2017 | $4,710,000 | +8.2% | 28,600 | -59.1% | 0.02% | +5.3% |
Q3 2017 | $4,354,000 | +0.7% | 69,900 | +28.7% | 0.02% | 0.0% |
Q2 2017 | $4,324,000 | -41.3% | 54,300 | -47.6% | 0.02% | -40.6% |
Q1 2017 | $7,362,000 | +39.5% | 103,600 | +0.2% | 0.03% | +39.1% |
Q4 2016 | $5,279,000 | +17.6% | 103,400 | +6.1% | 0.02% | +15.0% |
Q3 2016 | $4,489,000 | +1794.1% | 97,500 | +1217.6% | 0.02% | +1900.0% |
Q1 2016 | $237,000 | -68.7% | 7,400 | -43.1% | 0.00% | -66.7% |
Q4 2015 | $757,000 | +37.6% | 13,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $550,000 | -42.0% | 13,000 | 0.0% | 0.00% | -25.0% |
Q2 2015 | $949,000 | – | 13,000 | – | 0.00% | – |
Q1 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2014 | $73,000 | -42.1% | 2,000 | -50.0% | 0.00% | – |
Q3 2014 | $126,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |